Literature DB >> 19587348

Prostate-cancer screening.

William J Catalona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19587348     DOI： 10.1056/NEJMc090849

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Prostate-specific antigen screening can be beneficial to younger and at-risk men.

Authors:  Monique J Roobol; Chris H Bangma; Stacy Loeb
Journal:  CMAJ       Date:  2012-05-07       Impact factor: 8.262

2.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

3.  Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Authors:  Andrew J Vickers; Angel M Cronin; Thomas Björk; Jonas Manjer; Peter M Nilsson; Anders Dahlin; Anders Bjartell; Peter T Scardino; David Ulmert; Hans Lilja
Journal:  BMJ       Date:  2010-09-14

4.  To screen or nor to screen: the prostate cancer dilemma.

Authors:  Nelson N Stone; E David Crawford
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.